News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
HHLR ADVISORS, LTD.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 9.9% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 6.4% stake in Cytek Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.3% stake in Gossamer Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 7.6% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 11.9% stake in MOGU Inc. |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 15.6% stake in Bright Scholar Education Holdings Limited |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 19.1% stake in Yatsen Holding Ltd. |
| 07/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 3.3% stake in KE Holdings Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.6% stake in Aligos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Leap Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Beam Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Apellis Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 18% stake in Yatsen Holding Ltd. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 5.2% stake in Root, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 7.3% stake in Apellis Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 11% stake in MOGU Inc. |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 9.9% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 14.9% stake in iQIYI, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|